Acceder
  1. Inicio
  2. Perfil de chiquitina
  3. Participaciones

Participaciones del usuario chiquitina

chiquitina 19/06/12 15:08
Ha respondido al tema Farmas USA
pues si,se codea con los grandes pero sera una mariconada cuando comparemos con thld en el 7/4/2015 jajaja
Ir a respuesta
chiquitina 18/06/12 16:58
Ha respondido al tema Farmas USA
para julio,la comente hace unos dias PGNX para septiembre NPSP bonito grafico para vigilar.
Ir a respuesta
chiquitina 15/06/12 22:09
Ha respondido al tema Farmas USA
los que subieron a zalicus 1,36 si jejeje http://seekingalpha.com/article/662721-zalicus-z160-could-change-the-world-s-pain-market?source=email_rt_article_title&ifp=0 buen finde
Ir a respuesta
chiquitina 15/06/12 14:36
Ha respondido al tema Farmas USA
CNBC this morning had an interview with Dr.Toby Cosgrove, he is president and chief executive officer of Cleveland Clinic. As CEO, Dr. Cosgrove presides over a $5 billion healthcare system. This part starts at 1:55 on the Video. http://video.cnbc.com/gallery/?video=3000095374&play=1 He said this morning on CNBC that the country needs to get control of obesity in regards to health care costs. 1/3 OF U.S. IS OBESE AND ACCOUNTS FOR 10% OF HEALTH CARE COSTS IN U.S.AND EXPECTED TO GO TO 20% BY BY 2020. I would think the goverment would like to start with a safe and effective treatment like Locaserin. estaran presionando?
Ir a respuesta
chiquitina 15/06/12 14:07
Ha respondido al tema Farmas USA
video Adam Feuerstein & Gregg Greenberg...ARNA.... http://www.thestreet.com/_yahoo/video/11581041/the-next-big-thing-in-biotech-arena.html?cm_ven=YAHOOV&cm_cat=FREE&cm_ite=NA&s=1
Ir a respuesta
chiquitina 13/06/12 14:34
Ha respondido al tema Farmas USA
grafico pgnx http://investorshub.advfn.com/boards/read_msg.aspx?message_id=76553216
Ir a respuesta
chiquitina 07/06/12 20:30
Ha respondido al tema Zalicus
sobre zalicus http://onlycharts.com/2012/06/06/zlcs-chart-analysis/
Ir a respuesta
chiquitina 07/06/12 17:26
Ha respondido al tema Zalicus
esto es lo que comentan de HZNP--some DD: Market is huge: Arthritis is the most common cause of disability in the United States, limiting the activities of nearly 21 million adults. About LODOTRA LODOTRA is a proprietary programmed-release formulation of low-dose prednisone and has received regulatory approval for the treatment of moderate to severe active rheumatoid arthritis (RA) when accompanied by morning stiffness in Europe where it is promoted by Mundipharma. LODOTRA utilizes SkyePharma's proprietary Geoclock™ technology. PDUFA--July 27 Insiders and institutions-- Net institutional purchases in the current quarter at 2.3M shares, which represents about 9.07% of the company's float of 25.35M shares. Over the last six months, insiders were net buyers of 1,511,150 shares, which represents about 5.96% of the company's 25.35M share float. http://tiny.cc/5aj8ew From various sources: ***lodotra already approved in EU ***private placement was done at 3.62 + warrants for .25 shrs, exercise 4.308 ***generic threat put off for 30 months ***has partner, Mundipharma, and new manufacturing in Canada ***they announced expansion into latin america ***outperform or accumulate ratings(2) price targets $10 and $16 ***insiders buying at higher prices ***for me this is a mid-term swing I think we will see significantly higher price before 7/27. saludos
Ir a respuesta